Working… Menu

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01847573
Recruitment Status : Terminated (Dosing stopped)
First Posted : May 7, 2013
Last Update Posted : September 3, 2020
Information provided by (Responsible Party):
Processa Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 30, 2016
Actual Study Completion Date : March 30, 2016
Certification/Extension First Submitted : July 23, 2019